Stockscreener 앱 받기
28.61
1.49%
0.42
시간 외 거래:
28.78
0.17
+0.59%
Alkermes Plc 주식(ALKS)의 최신 뉴스
Is Alkermes plc (8AK) stock a fit for income portfoliosRecession Risk & Consistent Growth Stock Picks - newser.com
Alkermes stock rating reiterated at Neutral by H.C. Wainwright - Investing.com Australia
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal - Finviz
Will Alkermes plc (8AK) stock benefit from mergersWeekly Investment Recap & Community Supported Trade Ideas - newser.com
Is Alkermes plc (8AK) stock good for wealth creation2025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
Is Alkermes plc (8AK) stock among top earnings playsEarnings Risk Summary & Free Weekly Watchlist of Top Performers - newser.com
What momentum indicators show for Alkermes plc stockWeekly Trade Review & Accurate Intraday Trade Tips - newser.com
Will Alkermes plc (8AK) stock benefit from infrastructure billMarket Movers & Growth Focused Stock Pick Reports - newser.com
Applying Elliott Wave Theory to Alkermes plcWeekly Risk Report & Daily Chart Pattern Signals - newser.com
What recovery options are there for Alkermes plcMarket Trend Report & Reliable Entry Point Alerts - newser.com
Alkermes Fires Back In Bidding War With Lundbeck Over Avadel - Citeline News & Insights
Alkermes, Avadel Bump Deal To $2.37B After Alternate Bid - Law360
Avadel Pharmaceuticals agrees to sweetened $2.37B takeover bid from Alkermes amid bidding war - The Business Journals
Alkermes increases offer for Avadel to $21 in cash plus CVR - Investing.com Nigeria
What data driven models say about Alkermes plc’s futureChart Signals & Proven Capital Preservation Tips - newser.com
Risk vs reward if holding onto Alkermes plcQuarterly Portfolio Review & Reliable Volume Spike Trade Alerts - newser.com
ALKS: NT2 study data support flexible orexin dosing, robust safety, and strategic market expansion - TradingView
Alkermes prevails over Lundbeck in Avadel bidding war - Pharmaceutical Technology
Insmed Stock Rise on EU Nod for Lung Disease Drug, Brinsupri - Finviz
Avadel board backs Alkermes' higher offer over Lundbeck proposal - Reuters
Avadel Pharmaceuticals Agrees to Alkermes’ Revised Acquisition Offer - PharmExec.com
Alkermes Faces Bidding Battle For Avadel Pharmaceuticals - Finimize
Alkermes Faces Pressure to Secure the Buyout of Avadel After Lundbeck's Unsolicited Bid, RBC Says - MarketScreener
Alkermes escalates bidding war; US biotech risks ‘falling behind’ China - BioPharma Dive
Alkermes Ups Bid for Avadel to $2.37 Billion After Rival Offer - Contract Pharma
H Lundbeck A/S says noted that our offer for acquiring Avadel no longer is considered superior by their board, we are currently considering our options - MarketScreener
Alkermes (ALKS) Increases Buyout Offer for Avadel Pharmaceuticals (AVDL) - GuruFocus
Alkermes raises offer for Avadel acquisition and secures $1.5 billion loan facility - Investing.com Australia
How high can Alkermes plc stock goWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com
Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid - MSN
Why Alkermes plc stock is a must watch in 2025July 2025 Analyst Calls & Real-Time Stock Price Movement Reports - newser.com
Race For Avadel Heats Up: Alkermes Raises Offer To Secure $2.37B Deal After Lundbeck Challenge - MSN
Alkermes lifts Avadel buyout offer after Lundbeck bid (ALKS) - Seeking Alpha
Alkermes Raises Offer to Acquire Avadel Pharmaceuticals - MarketScreener
Alkermes raises offer for Avadel acquisition and secures $1.5 billion loan facility By Investing.com - Investing.com South Africa
Alkermes Increases Offer for Avadel Acquisition - TipRanks
Avadel Pharmaceuticals Amends Agreement with Alkermes - TipRanks
3.24%
자본화:
|
볼륨(24시간):